AP2048A - Diazepinoindole derivatives as kinase inhibitors - Google Patents
Diazepinoindole derivatives as kinase inhibitorsInfo
- Publication number
- AP2048A AP2048A AP2005003353A AP2005003353A AP2048A AP 2048 A AP2048 A AP 2048A AP 2005003353 A AP2005003353 A AP 2005003353A AP 2005003353 A AP2005003353 A AP 2005003353A AP 2048 A AP2048 A AP 2048A
- Authority
- AP
- ARIPO
- Prior art keywords
- kinase inhibitors
- diazepinoindole
- derivatives
- diazepinoindole derivatives
- kinase
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/06—Peri-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/06—Peri-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43939603P | 2003-01-09 | 2003-01-09 | |
PCT/IB2004/000026 WO2004063198A1 (en) | 2003-01-09 | 2004-01-05 | Diazepinoindole derivatives as kinase inhibitors |
Publications (2)
Publication Number | Publication Date |
---|---|
AP2005003353A0 AP2005003353A0 (en) | 2005-09-30 |
AP2048A true AP2048A (en) | 2009-09-24 |
Family
ID=32713475
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AP2005003353A AP2048A (en) | 2003-01-09 | 2004-01-05 | Diazepinoindole derivatives as kinase inhibitors |
Country Status (35)
Country | Link |
---|---|
US (3) | US6967198B2 (sr) |
EP (2) | EP1947102A1 (sr) |
JP (1) | JP3990718B2 (sr) |
KR (1) | KR100697746B1 (sr) |
CN (1) | CN1759118B (sr) |
AP (1) | AP2048A (sr) |
AT (1) | ATE404564T1 (sr) |
AU (1) | AU2004203977B2 (sr) |
BR (1) | BRPI0406701A (sr) |
CA (1) | CA2512683C (sr) |
CR (1) | CR7899A (sr) |
CY (1) | CY1108408T1 (sr) |
DE (1) | DE602004015724D1 (sr) |
DK (1) | DK1585749T3 (sr) |
EA (1) | EA009337B1 (sr) |
EC (1) | ECSP055911A (sr) |
ES (1) | ES2309484T3 (sr) |
GE (1) | GEP20084367B (sr) |
HK (1) | HK1086257A1 (sr) |
HR (1) | HRP20050624A2 (sr) |
IL (1) | IL169082A (sr) |
IS (1) | IS7884A (sr) |
MA (1) | MA27703A1 (sr) |
MX (1) | MXPA05007352A (sr) |
NO (1) | NO20053775L (sr) |
NZ (1) | NZ540638A (sr) |
OA (1) | OA13017A (sr) |
PL (1) | PL378372A1 (sr) |
PT (1) | PT1585749E (sr) |
RS (1) | RS20050522A (sr) |
SI (1) | SI1585749T1 (sr) |
TN (1) | TNSN05176A1 (sr) |
UA (1) | UA80733C2 (sr) |
WO (1) | WO2004063198A1 (sr) |
ZA (1) | ZA200504674B (sr) |
Families Citing this family (41)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1467730A4 (en) * | 2002-01-22 | 2010-03-10 | Univ California | Non-steroid ligands for the glucocorticoid receptor, compositions and uses thereof |
CN1759118B (zh) * | 2003-01-09 | 2010-12-08 | 美国辉瑞有限公司 | 作为激酶抑制剂的二氮杂*并吲哚衍生物 |
KR20070107034A (ko) * | 2005-02-18 | 2007-11-06 | 아스트라제네카 아베 | Chk1 억제제에 대한 반응성의 결정 방법 |
PT1869020E (pt) | 2005-03-29 | 2010-12-23 | Icos Corp | Derivados de heteroaril-ureia úteis para a inibição de chk1 |
GB0510390D0 (en) * | 2005-05-20 | 2005-06-29 | Novartis Ag | Organic compounds |
SI1896040T1 (sl) | 2005-06-29 | 2012-12-31 | Threshold Pharmaceuticals, Inc. | Fosforamidatna alkilatorska predzdravila |
CA2619048A1 (en) | 2005-08-15 | 2007-02-22 | The Regents Of The University Of California | Vegf-activated fas ligands |
CN101248184B (zh) | 2005-08-25 | 2013-01-16 | 宇部兴产株式会社 | 光学活性(S或R)-α-氨基酸及光学活性(S或R)-α-氨基酸酯的制造方法 |
JP2009506077A (ja) * | 2005-08-26 | 2009-02-12 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | 非ステロイド性抗アンドロゲン剤 |
EP2004655A1 (en) * | 2006-04-04 | 2008-12-24 | Pfizer Products Incorporated | Polymorphic forms of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4 l)-1-oxo-2,6-dihydro-1h-ý1,2¨diazepinoý4,5,6-cd¨indol-8-yl)acetamide |
WO2007113671A1 (en) * | 2006-04-04 | 2007-10-11 | Pfizer Products Inc. | Combination therapy of (2r,z)-2-amino-2-cyclohexyl-n-(5-(1-methyl-1h-pyrazol-4-yl)-1-oxo-2,6-dihydro-1h-[1,2]diazepino[4,5,6-cd]indol-8-yl)acetamide |
CA2669982A1 (en) * | 2006-11-17 | 2008-05-29 | Schering Corporation | Combination therapy for proliferative disorders |
US8158656B2 (en) * | 2008-05-16 | 2012-04-17 | Shenzhen Chipscreen Biosciences Ltd. | 2-indolinone derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
JP5576370B2 (ja) * | 2008-08-06 | 2014-08-20 | ファイザー・インク | Chk−1阻害剤としての6置換2−ヘテロシクリルアミノピラジン化合物 |
WO2010040527A1 (en) * | 2008-10-10 | 2010-04-15 | Priaxon Ag | Novel compounds which modulate kinase activity |
US8314108B2 (en) | 2008-12-17 | 2012-11-20 | Eli Lilly And Company | 5-(5-(2-(3-aminopropoxy)-6-methoxyphenyl)-1H-pyrazol-3-ylamino)pyrazine-2-carbonitrile, pharmaceutically acceptable salts thereof, or solvate of salts |
US8663210B2 (en) | 2009-05-13 | 2014-03-04 | Novian Health, Inc. | Methods and apparatus for performing interstitial laser therapy and interstitial brachytherapy |
US8211901B2 (en) | 2009-05-22 | 2012-07-03 | Shenzhen Chipscreen Biosciences Ltd. | Naphthamide derivatives as multi-target protein kinase inhibitors and histone deacetylase inhibitors |
CN101906076B (zh) | 2009-06-04 | 2013-03-13 | 深圳微芯生物科技有限责任公司 | 作为蛋白激酶抑制剂和组蛋白去乙酰化酶抑制剂的萘酰胺衍生物、其制备方法及应用 |
CA2835195A1 (en) | 2011-05-06 | 2012-11-15 | Zafgen, Inc. | Tricyclic sulfonamide compounds and methods of making and using same |
WO2013096687A1 (en) * | 2011-12-22 | 2013-06-27 | Threshold Pharmaceuticals, Inc. | Administration of hypoxia activated prodrugs in combination with chk1 inhibitors for treating cancer |
MX353578B (es) * | 2011-12-31 | 2018-01-19 | Beigene Ltd | Dihidrodiazpinocarbazolonas tetra o penta-ciclicas fusionadas como inhibidores de poli (adp-ribosa) polimerasa (parp). |
JP5913631B2 (ja) | 2011-12-31 | 2016-05-11 | ベイジーン リミテッド | Parp阻害剤としての縮合四環式または縮合五環式ピリドフタラジノン |
CN102746211B (zh) * | 2012-06-27 | 2015-05-27 | 上海泰坦化学有限公司 | 一种取代吲哚-3-甲醛类化合物的制备方法 |
TWI633107B (zh) * | 2013-05-22 | 2018-08-21 | 開曼群島商百濟神州生物科技有限公司 | 作為parp抑制劑的稠合四或五環二氫二氮呯并咔唑酮 |
KR20160099081A (ko) | 2013-07-26 | 2016-08-19 | 업데이트 파마 인코포레이트 | 비산트렌의 치료 효과 개선용 조합 방법 |
WO2015069489A1 (en) | 2013-11-06 | 2015-05-14 | Merck Patent Gmbh | Predictive biomarker for hypoxia-activated prodrug therapy |
RS59054B1 (sr) | 2014-06-17 | 2019-08-30 | Vertex Pharma | Postupak za lečenje raka korišćenjem kombinacije chk1 i atr inhibitora |
CN107922425B (zh) * | 2015-08-25 | 2021-06-01 | 百济神州有限公司 | 制备parp抑制剂、结晶形式的方法及其用途 |
US11464774B2 (en) | 2015-09-30 | 2022-10-11 | Vertex Pharmaceuticals Incorporated | Method for treating cancer using a combination of DNA damaging agents and ATR inhibitors |
US11202782B2 (en) | 2016-09-27 | 2021-12-21 | Beigene, Ltd. | Treatment cancers using a combination comprising PARP inhibitors |
JP6541635B2 (ja) * | 2016-10-28 | 2019-07-10 | ベイジーン リミテッド | Parp阻害剤としての縮合四環式または縮合五環式ジヒドロジアゼピノカルバゾロン |
WO2018157794A1 (en) | 2017-02-28 | 2018-09-07 | Beigene, Ltd. | Crystalline forms of salts of fused tera or penta-cyclic dihydrodiazepinocarazolones, and uses thereof |
US11661581B2 (en) * | 2017-05-25 | 2023-05-30 | University Of Massachusetts | Use of CDK inhibitors to enhance growth and self-renewal of progenitor cells |
SG11202002032SA (en) * | 2017-09-22 | 2020-04-29 | Jubilant Epipad LLC | Heterocyclic compounds as pad inhibitors |
EP3461480A1 (en) | 2017-09-27 | 2019-04-03 | Onxeo | Combination of a dna damage response cell cycle checkpoint inhibitors and belinostat for treating cancer |
CN113631179A (zh) * | 2019-01-25 | 2021-11-09 | 努梅迪公司 | 用于治疗特发性肺纤维化的方法 |
CN114072410B (zh) * | 2019-08-01 | 2023-08-01 | 正大天晴药业集团股份有限公司 | 作为parp抑制剂吲哚并七元酰肟化合物 |
WO2021104461A1 (zh) | 2019-11-29 | 2021-06-03 | 南京明德新药研发有限公司 | 二氮杂吲哚类衍生物及其作为Chk1抑制剂的应用 |
US20230330244A1 (en) * | 2020-07-13 | 2023-10-19 | Ontario Institute For Cancer Research (Oicr) | Nicotinamide phosphoribosyltransferase (nampt) inhibitor-conjugates and uses thereof |
TW202214649A (zh) * | 2020-07-31 | 2022-04-16 | 大陸商正大天晴藥業集團股份有限公司 | 用作parp抑制劑的吲哚并七員醯肟類似物的結晶及其製備方法 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000042040A1 (en) * | 1999-01-11 | 2000-07-20 | Agouron Pharmaceuticals, Inc. | Tricyclic inhibitors of poly(adp-ribose) polymerases |
WO2002044183A2 (en) * | 2000-12-01 | 2002-06-06 | Guilford Pharmaceuticals Inc. | Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB9722320D0 (en) | 1997-10-22 | 1997-12-17 | Janssen Pharmaceutica Nv | Human cell cycle checkpoint proteins |
US6383744B1 (en) | 1998-07-10 | 2002-05-07 | Incyte Genomics, Inc. | Human checkpoint kinase |
JP2002526450A (ja) | 1998-09-18 | 2002-08-20 | スミスクライン・ビーチャム・コーポレイション | Chk1キナーゼ阻害物質 |
ATE388226T1 (de) | 1999-08-27 | 2008-03-15 | Novartis Vaccines & Diagnostic | Chimerische antisense-oligonukleotide und zelltransfektions-zusammensetzungen davon |
ECSP003637A (es) | 1999-08-31 | 2002-03-25 | Agouron Pharma | Inhibidores triciclicos de poli (adp-ribosa) polimerasas |
US6670167B1 (en) | 1999-11-01 | 2003-12-30 | Agouron Pharmaceuticals, Inc. | Catalytic domain of the human effector cell cycle checkpoint protein kinase materials and methods for identification of inhibitors thereof |
WO2001021771A2 (en) | 1999-09-22 | 2001-03-29 | Canbas Co., Ltd. | Compositions and methods for inhibiting g2 cell cycle arrest and sensitizing cells to dna damaging agents |
US6211164B1 (en) | 2000-03-10 | 2001-04-03 | Abbott Laboratories | Antisense oligonucleotides of the human chk1 gene and uses thereof |
UA76977C2 (en) | 2001-03-02 | 2006-10-16 | Icos Corp | Aryl- and heteroaryl substituted chk1 inhibitors and their use as radiosensitizers and chemosensitizers |
CN1759118B (zh) * | 2003-01-09 | 2010-12-08 | 美国辉瑞有限公司 | 作为激酶抑制剂的二氮杂*并吲哚衍生物 |
-
2004
- 2004-01-05 CN CN2004800063838A patent/CN1759118B/zh not_active Expired - Fee Related
- 2004-01-05 EP EP08155745A patent/EP1947102A1/en not_active Withdrawn
- 2004-01-05 ES ES04700145T patent/ES2309484T3/es not_active Expired - Lifetime
- 2004-01-05 DE DE602004015724T patent/DE602004015724D1/de not_active Expired - Lifetime
- 2004-01-05 WO PCT/IB2004/000026 patent/WO2004063198A1/en active IP Right Grant
- 2004-01-05 EA EA200500893A patent/EA009337B1/ru not_active IP Right Cessation
- 2004-01-05 SI SI200430830T patent/SI1585749T1/sl unknown
- 2004-01-05 MX MXPA05007352A patent/MXPA05007352A/es active IP Right Grant
- 2004-01-05 CA CA2512683A patent/CA2512683C/en not_active Expired - Fee Related
- 2004-01-05 PL PL378372A patent/PL378372A1/pl not_active Application Discontinuation
- 2004-01-05 AU AU2004203977A patent/AU2004203977B2/en not_active Ceased
- 2004-01-05 OA OA1200500197A patent/OA13017A/en unknown
- 2004-01-05 JP JP2006500278A patent/JP3990718B2/ja not_active Expired - Fee Related
- 2004-01-05 AT AT04700145T patent/ATE404564T1/de not_active IP Right Cessation
- 2004-01-05 GE GEAP20048886A patent/GEP20084367B/en unknown
- 2004-01-05 KR KR1020057012806A patent/KR100697746B1/ko not_active IP Right Cessation
- 2004-01-05 RS YUP-2005/0522A patent/RS20050522A/sr unknown
- 2004-01-05 NZ NZ540638A patent/NZ540638A/en unknown
- 2004-01-05 EP EP04700145A patent/EP1585749B1/en not_active Expired - Lifetime
- 2004-01-05 BR BR0406701-0A patent/BRPI0406701A/pt not_active IP Right Cessation
- 2004-01-05 AP AP2005003353A patent/AP2048A/xx active
- 2004-01-05 DK DK04700145T patent/DK1585749T3/da active
- 2004-01-05 PT PT04700145T patent/PT1585749E/pt unknown
- 2004-01-09 US US10/754,171 patent/US6967198B2/en not_active Expired - Fee Related
- 2004-05-01 UA UAA200506730A patent/UA80733C2/uk unknown
-
2005
- 2005-06-08 ZA ZA200504674A patent/ZA200504674B/en unknown
- 2005-06-08 IL IL169082A patent/IL169082A/en not_active IP Right Cessation
- 2005-06-09 IS IS7884A patent/IS7884A/is unknown
- 2005-07-07 HR HR20050624A patent/HRP20050624A2/hr not_active Application Discontinuation
- 2005-07-08 EC EC2005005911A patent/ECSP055911A/es unknown
- 2005-07-08 TN TNP2005000176A patent/TNSN05176A1/fr unknown
- 2005-07-08 MA MA28375A patent/MA27703A1/fr unknown
- 2005-07-08 CR CR7899A patent/CR7899A/es unknown
- 2005-07-22 US US11/187,089 patent/US7132533B2/en not_active Expired - Fee Related
- 2005-08-08 NO NO20053775A patent/NO20053775L/no unknown
-
2006
- 2006-05-26 HK HK06106153.4A patent/HK1086257A1/xx not_active IP Right Cessation
- 2006-06-23 US US11/426,132 patent/US7462713B2/en not_active Expired - Fee Related
-
2008
- 2008-10-13 CY CY20081101127T patent/CY1108408T1/el unknown
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000042040A1 (en) * | 1999-01-11 | 2000-07-20 | Agouron Pharmaceuticals, Inc. | Tricyclic inhibitors of poly(adp-ribose) polymerases |
WO2002044183A2 (en) * | 2000-12-01 | 2002-06-06 | Guilford Pharmaceuticals Inc. | Benzoazepine and benzodiazepine derivatives and their use as parp inhibitors |
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AP2048A (en) | Diazepinoindole derivatives as kinase inhibitors | |
IL172132A0 (en) | Thienopyridone derivatives as kinase inhibitors | |
IL165515A0 (en) | Bisindolyl-maleimid derivatives as kinase inhibitors | |
IL173381A0 (en) | 2-aminophenyl-4-phenylpyrimidines as kinase inhibitors | |
IL173380A0 (en) | Pyridinylamino-pyrimidine derivatives as protein kinase inhibitors | |
IL173200A0 (en) | Piperidyl-quinazoline derivatives as tyrosine kinase inhibitors | |
AU2003271566A8 (en) | Pyrrolopyrazines as kinase inhibitors | |
IL172375A0 (en) | Chinazoline derivatives as aurora kinase inhibitors | |
TWI370127B (en) | Pyrazolylaminopyridine derivatives useful as kinase inhibitors | |
IL177278A0 (en) | Pyrazolotriazines as kinase inhibitors | |
HK1105592A1 (en) | Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors | |
PL373649A1 (en) | Kinase inhibitors | |
ZA200702394B (en) | Indozolone derivatives as 11b-HSD1 inhibitors | |
SI1569907T1 (sl) | Na nikotinamidu osnovani kinazni inhibitorji | |
IL175568A0 (en) | Azole-based kinase inhibitors | |
HK1071758A1 (en) | Pyrazolopyridines as cyclin dependent kinase inhibitors | |
EP1558609A4 (en) | KINASE INHIBITORS | |
PL378116A1 (pl) | Heterocykliczne inhibitory kinazy | |
ZA200703835B (en) | Heterocyclic substituted bisarylurea derivatives as kinase inhibitors | |
EP1569907A4 (en) | NICOTINAMIDE-BASED KINASE HEMMER | |
AU2003232362A8 (en) | 4-pyrazol-phenylalanine derivatives as ace-nep inhibitors | |
SI1483265T1 (sl) | Drivati purina kot inhibitoriji kinaze | |
AU2003906917A0 (en) | Imidazopyrazine-based kinase Inhibitors | |
SI1684750T1 (sl) | aminoariloksazolne spojine kot inhibitorji tirozin kinaze |